A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer
Clinical trial NCT02960906 · COMPLETED
Trial details
- NCT number
- NCT02960906
- Sponsor
- Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2021-02-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.